AE |
Adverse event |
AOMT |
Acetylserotonin-O-methyltransferase |
ASD |
Autism spectrum disorder |
CBT |
Cognitive behavioural therapy |
CSF |
Cerebrospinal Fluid |
DLMO |
Dim light melatonin onset |
DMT |
N,N-dimethyltryptamine |
DSPD |
Delayed sleep phase disorder |
EMA |
European Medicines Agency |
G-BA |
Joint Federal Committee (Gemeinsamer Bundesausschuss) |
Non24 |
Non-24 syndrome; deviation from 24 h circadian rhythmicity |
OL |
Off-label |
RCT |
Randomised controlled trial |
SE |
Sleep efficiency |
SMS |
Smith–Magenis syndrome |
SO |
Sleep onset |
SOL |
Sleep onset latency |
TST |
Total sleep time |
WASO |
Wake after sleep onset = awakenings; number and duration |